Proceedings of the National Academy of Sciences

Vol. 123, Issue 23 Issue 23 2026
81
Articles

Articles in this Issue

Trace fossils constrain the perceptual ranges of the earliest motile animals

Zekun Wang, Tianyun Shi Jun 09, 2026 10.1073/pnas.2609730123

The late Ediacaran marks a pivotal interval in early animal evolution, when benthic organisms began engaging with increasingly heterogeneous and dynamic seafloor environments. These shifts signal the...

Rethinking energy transition strategies for the European Union amid rising energy prices

Wenjun Meng, Jaime Nieto, Dabo Guan et al. Jun 09, 2026 10.1073/pnas.2609606123

Geopolitical tensions and the disruption of major energy imports have sharply elevated energy prices across the European Union (EU), creating a persistent energy supply gap and posing long-term challe...

“Alternative” or integrated role of mitochondrial glycerol-3-phosphate dehydrogenase

Hélène Lemieux, Clément Joël Lucien Chevret, Erich Gnaiger Jun 09, 2026 10.1073/pnas.2611388123

Coordinated expression and assembly of BiP, p58 <sup>IPK</sup> , and ER chaperone complexes maximize proinsulin folding in pancreatic β cells

Insook Jang, Alec Duffey, Pamela Itkin-Ansari et al. Jun 09, 2026 10.1073/pnas.2533617123

Proper proinsulin folding in the endoplasmic reticulum (ER) is prerequisite to producing bioactive insulin, and proinsulin misfolding causing β cell ER stress accompanies pancreatic β cell dysfunction...

Crotonylation impedes c-Myc oncogenic activity

Nicholas J. Wallbillich, Peng Liao, Rashmi Srivastava et al. Jun 09, 2026 10.1073/pnas.2530020123

c-Myc, an important oncoprotein, is highly regulated via posttranslational modifications. Herein, we report c-Myc crotonylation, an acylation stemming from the short-chain fatty acid crotonate. By bio...

A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance

Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou et al. Jun 09, 2026 10.1073/pnas.2610708123

Pancreatic ductal adenocarcinoma (PDAC) has one of the lowest cancer survival rates. Recent studies using RAS inhibitors have opened the door to more efficacious therapies although their beneficial ef...

All Issues

Journal Info

Publisher National Academy of Sciences
ISSN 0027-8424
E-ISSN 1091-6490
Subject Life Sciences
Language English
View Full Journal Page